Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

NRx Pharmaceuticals, Inc. NRXPW

Set alert

Price alert · NRXPW

All alert types
0.01 USD 0.00 0.00%

As of May 28, 9:30 AM ET

Bid
— × —
Ask
0.01 × —
0.0142 Day range 0.0142
0.0026 52-week range 0.0033
YTD
-61.10%
1 year
-61.10%
Open
0.0142
Prev close
0.0142
Mkt cap
361.78K
Vol
0
Avg vol
0
EPS
-6.25
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0142
High
0.0142
Forward P/E
0.00
Beta
1.27
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.00
200-d avg
0.00
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for NRXPW has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-15.47 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.0×
FY 2017: -807×FY 2018: 1377×FY 2019: 133×FY 2020: -162×FY 2021: -6.4×FY 2022: -18.5×FY 2023: -1.2×FY 2024: -0.9×FY 2025: -2.0×
FY 2017 5y median -2.0× FY 2025
P/S 47.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 47.3×
FY 2017 5y median 0.0× FY 2025
P/B -3.6×
FY 2017: 1.3×FY 2018: 1.3×FY 2019: 1.8×FY 2020: -3.0×FY 2021: 108×FY 2022: 98.5×FY 2023: -3.0×FY 2024: -1.0×FY 2025: -3.6×
FY 2017 5y median -1.0× FY 2025
P/FCF -4.1×
FY 2017: -644×FY 2018: -192×FY 2019: -68.0×FY 2020: -58.8×FY 2021: -59.5×FY 2022: -18.4×FY 2023: -1.6×FY 2024: -2.2×FY 2025: -4.1×
FY 2017 5y median -4.1× FY 2025
EV/EBITDA -1.8×
FY 2017: -829×FY 2018: 1113×FY 2019: 113×FY 2020: -2.6×FY 2021: -23.8×FY 2022: -18.1×FY 2023: -1.3×FY 2024: -1.2×FY 2025: -1.8×
FY 2017 5y median -1.8× FY 2025
EV/Sales 41.5×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 41.5×
FY 2017 5y median 0.0× FY 2025
FCF Yield -24.3%
FY 2017: -0.2%FY 2018: -0.5%FY 2019: -1.5%FY 2020: -1.7%FY 2021: -1.7%FY 2022: -5.4%FY 2023: -62.2%FY 2024: -46.0%FY 2025: -24.3%
FY 2017 5y median -24.3% FY 2025

Profitability

Gross Margin 58.8%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 58.8%
FY 2017 5y median 0.0% FY 2025
Operating Margin -1324.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -1324.4%
FY 2017 5y median 0.0% FY 2025
Net Margin -2336.5%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: -2336.5%
FY 2017 5y median 0.0% FY 2025
ROE 179.6%
FY 2017: -0.2%FY 2018: 0.1%FY 2019: 1.4%FY 2020: 118.3%FY 2021: -447.3%FY 2022: -536.6%FY 2023: 257.0%FY 2024: 108.2%FY 2025: 179.6%
FY 2017 5y median 108.2% FY 2025
ROIC 106.0%
FY 2017: 0.0%FY 2018: -1.1%FY 2019: -1.9%FY 2020: 51.3%FY 2021: -446.5%FY 2022: -247.2%FY 2023: 1072.6%FY 2024: 118.4%FY 2025: 106.0%
FY 2017 5y median 106.0% FY 2025
ROA -220.9%
FY 2017: -0.2%FY 2018: 0.1%FY 2019: 1.3%FY 2020: -1760.5%FY 2021: -284.3%FY 2022: -154.0%FY 2023: -412.2%FY 2024: -688.2%FY 2025: -220.9%
FY 2017 5y median -284.3% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 17.7%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 29.1%FY 2020: -2993.3%FY 2021: -331.5%FY 2022: 53.4%FY 2023: 37.8%FY 2024: 28.6%FY 2025: 17.7%
FY 2017 FY 2025
EPS (diluted) 43.9%
FY 2017: 0.0%FY 2018: 161.8%FY 2019: 979.6%FY 2020: -288.8%FY 2021: -392.7%FY 2022: 91.9%FY 2023: -563.3%FY 2024: 39.9%FY 2025: 43.9%
FY 2017 FY 2025
Free Cash Flow -32.7%
FY 2017: 0.0%FY 2018: -248.4%FY 2019: -67.5%FY 2020: -186.0%FY 2021: -1563.4%FY 2022: -5.4%FY 2023: 45.5%FY 2024: 50.9%FY 2025: -32.7%
FY 2017 FY 2025

Financial Health

Current Ratio 0.3×
FY 2017: 5.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Quick Ratio 0.3×
FY 2017: 5.8×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 2.7×FY 2022: 1.7×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 0.3×
FY 2017 5y median 0.4× FY 2025
Debt / Equity -0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.1×FY 2020: -0.0×FY 2021: 0.0×FY 2022: 1.4×FY 2023: -0.8×FY 2024: -0.3×FY 2025: -0.0×
FY 2017 5y median -0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2017: 4.3×FY 2018: 8.2×FY 2019: 4.0×FY 2020: 0.0×FY 2021: 0.3×FY 2022: 0.2×FY 2023: -0.2×FY 2024: -0.2×FY 2025: 0.3×
FY 2017 5y median 0.2× FY 2025
Interest Coverage -24.2×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -394×FY 2021: -5289×FY 2022: 0.0×FY 2023: -230×FY 2024: -18.3×FY 2025: -24.2×
FY 2017 5y median -24.2× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31